Clinical Effectiveness and Cost-Effectiveness of Treatments for Patients With Chronic Pain
By D. Turk. The Clinical Journal of Pain, 2002
647 citations recorded by the source corpus.
Subfields: Anesthesiology and Pain Medicine, Pathology and Forensic Medicine, Pharmacology
View Paper: https://www.semanticscholar.org/paper/353b027ff1a0638ecd2f45f5f159a7fb59d0ed61
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Anesthesiology and Pain Medicine
In Pathology and Forensic Medicine
In Pharmacology
Citations in the corpus
- The effectiveness of virtual reality distraction for pain reduction: a systematic review. (2010, background): “Chronic pain is a particularly intractable, common, and costly health problem (Turk, 2002; Verhaak, Kerssens, Dekker, Sorbi, & Bensing, 1998).”
- The pain self‐efficacy questionnaire: Taking pain into account (2007, background): “The significance of this point is that lasting relief from chronic pain is rarely achieved by current treatments (Turk, 2002b).”
- Complementary and alternative medicine use among adults: United States, 2002. (2004, background): “The high prevalence of CAM use for these conditions is not surprising when one considers that one-quarter to one-third of the adult population might be suffering from one of these disorders in any given year (31,32), yet many forms of chronic pain are resistant to conventional medical treatment (33,”
- Core outcome measures for chronic pain clinical trials: IMMPACT recommendations (2003, methodology): “…or the MPI or BPI interference scale is used in a clinical trial, administration of a generic measure of physical functioning should be considered to obtain data that will allow comparisons with other disorders and that could be used in cost-effectiveness analyses (Thompson, 2002; Turk, 2002).”
- The economic costs of pain in the United States. (2012, background): “A review of 15 studies of chronic pain among adults found that prevalence estimates ranged from 2% to 40%, with a median of 15%.(23,31,33) Data from the 2009 National Health Interview Survey indicated that during a 3-month period, 16% of adults reported having a migraine or severe headache, 15% repo”